Romidepsin clinical trials

ROMIDEPSIN IN COMBINATION WITH CHOEP AS FIRST LINE TREATMENT BEFORE HEMATOPOIETIC STEM CELL TRANSPLANTATION IN YOUNG PATIENTS WITH NODAL PERIPHERAL T-CELL LYMPHOMAS: A PHASE I-II STUDY

This study looks at a new drug, Romidepsin, combined with standard treatment (CHOEP) for young people with certain types of lymphoma. It aims to find the safest dose and see how well it works before a stem cell transplant.